DarioHealth Corp. (NASDAQ:DRIO) shares fell to a low of $15.62 before closing at $17.54. Intraday shares traded counted 0.32 million, which was -11.5% lower than its 30-day average trading volume of 285.29K. DRIO’s previous close was $15.60 while the outstanding shares total 9.29M. The firm has a beta of 1.43. The stock’s Relative Strength Index (RSI) is 49.41, with weekly volatility at 10.66% and ATR at 1.63. The DRIO stock’s 52-week price range has touched low of $5.55 and a $31.85 high. The stock traded higher over the last trading session, gaining 12.44% on 05/20/21.
Investors have identified the Diagnostics & Research company DarioHealth Corp. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $259.77 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
DarioHealth Corp. (DRIO) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 88.26 million total, with 11.74 million as their total liabilities.
DRIO were able to record -10.6 million as free cash flow during the 08/17/2021 quarter of the year, this saw their quarterly net cash flow reduce by 52.64 million. In cash movements, the company had a total of -10.53 million as operating cash flow.
Potential earnings growth for DarioHealth Corp. (DRIO)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/17/2021 quarter of the year, DarioHealth Corp. recorded a total of 3.6 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 53.63% coming in sequential stages and their sales for the 08/17/2021 quarter increasing by 42.14%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 2.51 million trying to sell their products during the last quarter, with the result yielding a gross income of 1.08 million. This allows shareholders to hold on to 9.29M with the recently reported earning now reading -1.07 cents per share. This is a figure that compared to analyst’s prediction for their 08/17/2021 (-0.92 cents a share).
Having a look at the company’s valuation, the company is expected to record -2.48 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on DRIO sounds very interesting.
Is the stock of DRIO attractive?
In related news, Director, STERN ADAM K bought 639 shares of the company’s stock in a transaction that recorded on Sep 03. The purchase was performed at an average price of 6.66, for a total value of 4,256. As the purchase deal closes, the Director, STERN ADAM K now bought 639 shares of the company’s stock, valued at 4,256. Also, Director, STERN ADAM K bought 639 shares of the company’s stock in a deal that was recorded on Jul 03. The shares were cost at an average price of 6.66 per share, with a total market value of 4,256. In the last 6 months, insiders have changed their ownership in shares of company stock by 15.70%.